(67)Cu Production Capabilities: A Mini Review

Is the (67)Cu production worldwide feasible for expanding preclinical and clinical studies? How can we face the ingrowing demands of this emerging and promising theranostic radionuclide for personalized therapies? This review looks at the different production routes, including the accelerator- and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mou, Liliana, Martini, Petra, Pupillo, Gaia, Cieszykowska, Izabela, Cutler, Cathy S., Mikołajczak, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912090/
https://www.ncbi.nlm.nih.gov/pubmed/35268600
http://dx.doi.org/10.3390/molecules27051501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912090/
https://www.ncbi.nlm.nih.gov/pubmed/35268600
http://dx.doi.org/10.3390/molecules27051501

Ejemplares similares